My TMS offers Transcranial Magnetic Stimulation (TMS), a non-invasive, FDA-approved treatment that uses magnetic fields to stimulate the prefrontal cortex in patients with treatment-resistant depression. This therapy provides a drug-free alternative to traditional antidepressants, significantly improving mood and emotional well-being without systemic side effects.
Funding
Funding not disclosed
Founders
Product
Problem
Many individuals with major depressive disorder (MDD) do not respond adequately to traditional treatments like medication and psychotherapy, leading to persistent symptoms and impaired quality of life. These individuals often feel like they have run out of options for managing their depression.
Solution
My TMS offers Transcranial Magnetic Stimulation (TMS) therapy, an FDA-approved, non-invasive treatment for treatment-resistant depression. TMS uses targeted magnetic pulses to stimulate underactive areas of the brain, specifically the prefrontal cortex, which is responsible for mood regulation. By stimulating these areas, TMS can help restore normal brain function, reducing depressive symptoms and improving emotional well-being. The therapy is clinically proven to be effective and does not produce the systemic side effects associated with antidepressant medications or electroconvulsive therapy (ECT). My TMS offers both MagStim Repetitive TMS (rTMS) and BrainsWay Deep TMS (dTMS) to best suit patient preferences. In addition, My TMS offers SPRAVATO, a prescription medication for treatment-resistant depression and MDD with suicidal ideation.
Target Audience
The primary audience includes individuals with treatment-resistant depression who have not found relief through traditional methods such as medication and psychotherapy.
Features
- FDA-approved, non-invasive treatment for treatment-resistant depression
- Utilizes magnetic fields to stimulate the prefrontal cortex
- Does not involve drugs or systemic side effects
- Patients remain awake and alert during the entire treatment session
- Offers both MagStim Repetitive TMS (rTMS) and BrainsWay Deep TMS (dTMS)
- Magstim's rTMS uses a state-of-the-art stim-guide to visualize the brain’s target area on a computer screen before administering impulses and can conduct 3-minute treatment sessions
- BrainsWay’s Deep TMS (dTMS) stimulates some of the brain’s crucial surrounding regions with expanded depth and width ranges and can conduct 10-20 minute sessions
- SPRAVATO® is offered for Treatment-Resistant Depression (TRD) and Major Depressive Disorder (MDD) with Suicidal Ideation
- Typically involves 30-36 consecutive sessions, up to 20 minutes in length